Recursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy ...

Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their financials and risk profiles stack up?
Nasdaq

Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2024 ...

SALT LAKE CITY, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and ...
Yahoo Finance

Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Nasdaq

Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and ...

SALT LAKE CITY and TORONTO and MONTRÉAL, May 08, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today ...